Author:
Baptiste Bidon, Hajar Yaakoub, Arnaud Lanoue, Antoine Géry, Virginie Séguin, Claire Hoffmann Solène Le Gal, Gilles Nevez, Vincent Courdavault, Jean-Philippe Bouchara, Antonis Rokas, Gustavo H. Goldman, Jean-Pierre Gangneux, Jens C. Frisvad, Domenico Davolos, David Garon, Nicolas Papon
Abstract:
Objective. Mycophenolic acid (MPA) is a natural meroterpenoid known to inhibit inosine monophosphate dehydrogenase (IMPDH) involved in de novo purine synthesis. Because of its adverse effect on proliferation of human lymphocytes, MPA has been used for decades as an immunosuppressive agent. Biosynthesis of MPA was believed to be restricted to a very limited number of Penicillium species, including P. brevicompactum and P. roqueforti. However, recent findings evidenced that few xerophilic Aspergillus species are also capable of producing MPA. On the other hand, the biosynthetic gene cluster (BGC) for MPA production has only been investigated in P. brevicompactum and P. roqueforti. Given the medical and biotechnological importance of members of Penicillium and Aspergillus genera, we were interested in deciphering the origin and evolution of MPA biosynthetic pathway within their respective family Aspergillaceae.
Methods. Large-scale analysis of available genomic resources of Aspergillaceae led us to identifying very few species in Penicillium, Aspergillus, and Paecilomyces genera harboring either a complete or partial MPA BGC. Whole-genome sequencing was conducted for four xerophilic Aspergillus spp strains, including A. pseudoglaucus (E42) previously shown to produce MPA.
Results. Interestingly, genomic data confirmed the presence of a putative BGC for MPA production in A. pseudoglaucus (E42), though it dramatically differs in terms of genomic organisation from that described in P. brevicompactum. None of the three other sequenced Aspergillus species carried a functional BGC for MPA production or was able to produce MPA. We postulate that genetic determinants of MPA biosynthesis emerged early from a common ancestor of Aspergillaceae and were then retained in a narrow set of molds. Moreover, analysis of MPA production, susceptibility to MPA, and IMPDH protein sequences in members of Aspergillaceae showed that MPA producers are inevitably resistant to MPA, and that this resistance is likely the outcome of a combination of molecular events.
Conclusion. The current study provides insight into the origin and evolution of the biosynthesis of the important fungal secondary metabolite MPA. Implications of these findings in clinics and biotechnology are discussed.
Abstract Number: 47
Conference Year: 2024
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a